May 20, 2020 / 9:23 PM / 15 days ago

BRIEF-Tyme Announces Q4 And Fiscal Year 2020 Financial And Operating Results

May 20 (Reuters) - Tyme Technologies Inc:

* TYME ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2020 FINANCIAL AND OPERATING RESULTS

* TYME TECHNOLOGIES INC - TYME-88-PANC PIVOTAL TRIAL ENROLLING PATIENTS USING ORAL SM-88 AS A POTENTIAL TREATMENT FOR THIRD-LINE PANCREATIC CANCER

* TYME TECHNOLOGIES INC - EXPECTS ACTUAL NET QUARTERLY CASH BURN TO BE LOWER THAN OPERATIONAL CASH BURN AFTER ACCOUNTING FOR CASH INFLOWS

* TYME - BELIEVES CASH, CASH EQUIVALENTS AS OF QUARTER END, ANTICIPATED ACCESS TO ADDITIONAL CAPITAL, IS ADEQUATE TO FUND SOME CURRENT TRIALS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below